Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Epistaxis Market– Insights

Epistaxis, also known as nosebleed, occurs due to rupture of  small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive. Also, the interior of nose cannot tolerate certain factors that make the cells fragile and prone to burst resulting in bleeding. Nosebleeds are common during winter season, as upper respiratory infections mostly occur during this season.

In most cases, epistaxis responds effectively to nasal cauterization or nasal packaging or both the treatments. People experiencing recurrent bouts of nosebleeds are usually recommended to undergo surgical options or embolization procedures that are available in hospitals and ENT clinics. The most common treatment adopted for epistaxis patients is either chemical or electrical cautery. This method is easy to perform, cheap, and does not involve any serious risk. Cauterization refers to a procedure, in which a small tissue at the bleeding site is removed or burnt with the help of chemicals such as silver nitrate or mild electric shocks.

Moreover, various topical applications such as tranexamic acid are available in the market that helps to curtail nosebleeds. According to a research article published in International Journal of Otolaryngology in 2015, epistaxis is estimated to affect around 10-12% of the global population, of which around 80% patients require medical attention, as majority of epistaxis cases are not self-limiting and cannot be resolved due to intervention. An increasing number of cases of nosebleeds is expected to drive growth of the global epistaxis market.

The global epistaxis market size is estimated to be valued at US$ 145.9  million in 2019 and is expected to witness a CAGR of 5.4% over the forecast period (2019–2027).

Global Epistaxis Market Share (%) Analysis, By Product Type, 2019

Epistaxis  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

An increasing launch of products is expected to drive growth of the global epistaxis market

Key players are involved in research and development activities for technological advancements and innovation of epistaxis products. For instance, in 2016, Smith & Nephew launched a range of epistaxis devices with RAPID RHINO technology that has a blend of carboxymethylcellulose (CMC). Various similar technological advancements and strategic implementations by emerging and established market players are expected to drive the global epistaxis market growth.

Global Epistaxis Market- Restraints

The surgical procedure such as cauterization, which is commonly used for the treatment of epistaxis, caused large number of side effects such as pain, swelling, and running nose. This is expected to hinder the market growth over the forecast period.

Global Epistaxis Market- Regional Insights

On the basis of region, the global epistaxis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the epistaxis market over the forecast period, owing to increasing prevalence of diabetes in the U.S. For instance, according to the Centers for Disease Control and Prevention, in 2015, around 30.3 million people in the U.S. were suffering from diabetes, accounting for 9.4% of the total population.

Asia Pacific is expected to witness rapid growth in the epistaxis market, owing to increasing prevalence of hypertension. For instance, according to the global burden of disease report, in India, around 1.63 million deaths occurred due to hypertension in 2016.          

Global Epistaxis Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

Epistaxis  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Global Epistaxis Market- Competitive Landscape

Key players operating in the global epistaxis market include Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc.

Epistaxis, also known as nose bleeding, is a common clinical condition that results in loss of blood from the tissue lining of the nose. Epistaxis is usually classified as anterior or posterior epistaxis. Anterior epistaxis is defined as the bleeding from anterior septum of the nose, which is usually known as Kiesselbach plexus. Anterior epistaxis is also known as acute epistaxis and is the most commonly observed type of epistaxis that can be cured through various medical treatments. On the other hand, posterior nosebleeds originating from the back of nasal package, near the throat are a relatively less common clinical condition, as it may result in significantly large amount of blood loss. The posterior nosebleeds lead to massive blood loss and difficulty in breathing that may result in fatigue, paleness, and chest pain.

However, most nosebleeds are rarely life threatening and are benign, self-limiting, spontaneous, but recurrent. Epistaxis can be caused due to various factors such as lack of humidity in the atmosphere that results in drying of mucosal tract, hypertension, nasal tumors, and also, due to consumption of certain drugs, smoking, and alcohol.

Market Dynamics

There has been a steady rise in incidence of heart-related disorders leading to hypertension and high blood pressure in the recent past. Hypertension is one of the major causes of epistaxis and the increase in its prevalence is expected to be one of the major factors driving growth of the global epistaxis market. For instance, according to the World Health Organization (WHO), in 2019, 1.13 billion people worldwide suffered from hypertension.

Key features of the study:

  • This report provides in-depth analysis of the global epistaxis market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 – 2027, considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
  • It profiles key players in the global epistaxis market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study include Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global epistaxis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global epistaxis market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Epistaxis Market, By Indication:
    • Anterior Epistaxis
    • Posterior Epistaxis
  • Global Epistaxis Market, By Product Type:
    • Vasoconstrictors
    • Anesthetics
    • Antibiotic Ointments
    • Cauterizing Agents
  • Global Epistaxis Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Epistaxis Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Indication:
        • Anterior Epistaxis
        • Posterior Epistaxis
      • By Product Type:
        • Vasoconstrictors
        • Anesthetics
        • Antibiotic Ointments
        • Cauterizing Agents
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Indication:
        • Anterior Epistaxis
        • Posterior Epistaxis
      • By Product Type:
        • Vasoconstrictors
        • Anesthetics
        • Antibiotic Ointments
        • Cauterizing Agents
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Indication:
        • Anterior Epistaxis
        • Posterior Epistaxis
      • By Product Type:
        • Vasoconstrictors
        • Anesthetics
        • Antibiotic Ointments
        • Cauterizing Agents
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Indication:
        • Anterior Epistaxis
        • Posterior Epistaxis
      • By Product Type:
        • Vasoconstrictors
        • Anesthetics
        • Antibiotic Ointments
        • Cauterizing Agents
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Indication:
        • Anterior Epistaxis
        • Posterior Epistaxis
      • By Product Type:
        • Vasoconstrictors
        • Anesthetics
        • Antibiotic Ointments
        • Cauterizing Agents
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Indication:
        • Anterior Epistaxis
        • Posterior Epistaxis
      • By Product Type:
        • Vasoconstrictors
        • Anesthetics
        • Antibiotic Ointments
        • Cauterizing Agents
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
  • Company Profiles
      • Smith & Nephew*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medline Industries, Inc.
      • Bristol-Myers Squibb Pharma Company
      • Ciron Drugs
      • King Pharmaceuticals, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Indication
      • Market Snippet, By Product Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Industry Trend
    • Mergers and Acquisitions
    • Technology Overview
    • Regulatory Scenario
    • Epidemiology
    • New Product Approvals/Launches
    • PEST Analysis
  4.  Global Epistaxis Market, By Indication, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Anterior Epistaxis
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Posterior Epistaxis
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Global Epistaxis Market, By Product Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Vasoconstrictors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Anesthetics
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Antibiotic Ointments
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Cauterizing Agents
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Epistaxis Market, By Distribution Channel, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Retail Pharmacies
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Online Pharmacies
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Epistaxis Market, By Region, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Smith & Nephew*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medline Industries, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bristol-Myers Squibb Pharma Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Ciron Drugs
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • King Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 31 figures on “Epistaxis Market” - Global Forecast to 2027”

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner